Abstract:Background: Continuous understanding of the epidemiology and evolution of multidrug resistant TB (MDR-TB) is key to develop the appropriate strategies for preventing its epidemic. The present study aimed to investigate the longitudinal trend of its rates, transmissions and transition to extensively drug resistant TB(XDR-TB), in an attempt to adjust the TB control activities in eastern rural China. Methods: The data presented here span 8 years (2003-2010) and consisted of three population-based investigation of drug resistant TB in terms of socio-demographic and clinical characteristics of drug resistant TB cases as well as the microbiological and molecular features of their infected Mtb strains, respectively in one 19 years’ DOTS covered eastern rural county: Deqing (DQ) and the other 9 years’ DOTS covered Guanyun (GY). Results: Within 9 years’ study, 901 TB patients were identified at local TB dispensaries in two counties, with 254 resistant to at least one of 1st line drugs. Of the 135 MDR-TB isolates, 6 were XDR-TB. Rate of drug resistant TB remained stable, even reduced in some period both in two counties, while the rate of MDR-TB and MDR-TB plus resistance to fluoroquinolones increased significantly respectively from 14.5% and 5.1% in 2003/2004 to 21.3% and 9.7% in 2009/2010. The IS6110 RFLP genotyping revealed the 21 clusters involving 48(28.4%) drug resistant TB cases in DQ and 28 clusters involving 59(32.1%) drug resistant TB cases in GY. The clustering proportion increased among the drug resistant TB cases especially for MDR-TB over the study period, reaching 52%(DQ) and 48%(GY) in 2010. And 2 XDR-TB isolates was identified within only 2 clusters 0f drug resistant Mtb in DQ. Designated as subtypes of Beijing family, totally 3 clusters (11 drug resistant TB cases) typical with katG315Thr mutation, persisted throughout the study period in two counties. Conclusion: A high increased recent transmission of MDR-TB might implicate it necessary to improve the effectiveness on diagnosis and treatment of MDR-TB. Despite an increasing trend of MDR plus the resistant to fluoroquinolones, the low proportion of XDR-TB among MDR-TB might indicate it neccessary to cautiously introduce some of 2 line drugs in MDR-TB treatment in China.

Prevalence of Fluoroquinolone Resistance among Tuberculosis Patients in Shanghai, China

Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.

Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis

Ofloxacin Resistance in Patients with Pulmonary Tuberculosis in Shanghai,China

Characterization of Gyra and Gyrb Mutations and Fluoroquinolone Resistance in Mycobacterium Tuberculosis Clinical Isolates from Hubei Province, China

Gyra/b Fluoroquinolone Resistance Allele Profiles Amongst Mycobacterium Tuberculosis Isolates from Mainland China

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.

Population-based investigation of fluoroquinolones resistant tuberculosis in rural eastern China.

Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis.

Increased Prevalence of Levofloxacin-Resistant Mycobacterium Tuberculosis in China is Associated with Specific Mutations Within the Gyra Gene

Fluoroquinolone Resistance among Neisseria Gonorrhoeae Isolates from Shanghai, China: Detection of Quinolone Resistance-Determining Region Mutations.

The Emerging Threat of Fluroquinolone-, Bedaquiline-, and Linezolid-Resistant Mycobacterium Tuberculosis in China: Observations on Surveillance Data.

Fluoroquinolone susceptibility and quinolone resistance determining region mutations in Streptococcus pneumoniae isolates from Shanghai

Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study

Transmission of Drug-Resistant Tuberculosis among Treated Patients in Shanghai, China

SpecificgyrAgene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance Inmycobacterium Tuberculosisisolates from Beijing, China

Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant Mycobacterium tuberculosis isolates

Fluoroquinolone Resistance and Mutation Patterns in Gyra and Parc Genes in Neisseria Gonorrhoeae Isolates from Shanghai, China

[The Prevalence and Risk Factors of Drug-Resistant Tuberculosis among Migratory Population in Shanghai, China].